期刊
BRITISH JOURNAL OF PHARMACOLOGY
卷 -, 期 -, 页码 -出版社
WILEY
DOI: 10.1111/bph.15260
关键词
abdominal aortic aneurysm; mouse models; pathology
资金
- Queensland Government
- Study, Education and Research Trust Fund
- Townsville Hospital and Health Service
- National Health and Medical Research Council [1117601, 1062671, 1079369, 1098717]
- National Health and Medical Research Council of Australia [1062671, 1098717] Funding Source: NHMRC
Abdominal aortic aneurysm (AAA) rupture is estimated to cause 200,000 deaths each year. Currently, the only treatment for AAA is surgical repair; however, this is only indicated for large asymptomatic, symptomatic or ruptured aneurysms, is not always durable, and is associated with a risk of serious perioperative complications. As a result, patients with small asymptomatic aneurysms or who are otherwise unfit for surgery are treated conservatively, but up to 70% of small aneurysms continue to grow, increasing the risk of rupture. There is thus an urgent need to develop drug therapies effective at slowing AAA growth. This review describes the commonly used mouse models for AAA. Recent research in these models highlights key roles for pathways involved in inflammation and cell turnover in AAA pathogenesis. There is also evidence for long non-coding RNAs and thrombosis in aneurysm pathology. Further well-designed research in clinically relevant models is expected to be translated into effective AAA drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据